© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
November 19, 2020
Institutions are replacing innovator biologics with their biosimilars, often to take advantage of the financial benefits.
December 04, 2019
Drug shortages and rising prices remain a major issue, with drug pricing legislation on a national level going nowhere fast, and a new gene therapy becoming the most expensive drug approved by the FDA. The opioid epidemic continues to hold the attention of health care providers and organizations, and burnout is increasingly recognized as a problem that needs addressing.
July 19, 2019
The United States is on the cusp of seeing significantly more activity related to these products.